Detalles de la búsqueda
1.
The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung cancer.
Nature;
600(7888): 319-323, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34819663
2.
KEYNOTE-434 part B: A phase 1 study evaluating the combination of epacadostat, pembrolizumab, and chemotherapy in Japanese patients with previously untreated advanced non-small-cell lung cancer.
Invest New Drugs;
2024 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38530565
3.
Multi-institutional study of osimertinib dose-optimization in non-small cell lung cancer patients with EGFR activating mutation aged 70 years or older ('MONEY' trial).
Jpn J Clin Oncol;
2024 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38520037
4.
Phase 2 trial of crizotinib in Japanese patients with advanced NSCLC harboring a MET gene alteration: a Co-MET study.
Int J Clin Oncol;
2024 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38758397
5.
Phase I study of the irreversible fibroblast growth factor receptor 1-4 inhibitor futibatinib in Japanese patients with advanced solid tumors.
Cancer Sci;
114(2): 574-585, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35838190
6.
Prognostic impact and gene expression analysis of peri-tumoral alveolar macrophage in resected lung adenocarcinoma.
Cancer Sci;
114(8): 3423-3432, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37264761
7.
Clinicopathological significance of peritumoral alveolar macrophages in patients with resected early-stage lung squamous cell carcinoma.
Cancer Immunol Immunother;
72(7): 2205-2215, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36862151
8.
Observational study to predict the efficacy and optimal duration of nivolumab treatment in patients with previously treated advanced or recurrent non-small cell lung cancer.
Jpn J Clin Oncol;
53(2): 153-160, 2023 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36300307
9.
Predictive value of EGFR mutation in non-small-cell lung cancer patients treated with platinum doublet postoperative chemotherapy.
Cancer Sci;
113(1): 287-296, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34689382
10.
The real-world safety of atezolizumab as second-line or later treatment in Japanese patients with non-small-cell lung cancer: a post-marketing surveillance study.
Jpn J Clin Oncol;
52(6): 623-632, 2022 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35325169
11.
Molecular dynamics simulation-guided drug sensitivity prediction for lung cancer with rare EGFR mutations.
Proc Natl Acad Sci U S A;
116(20): 10025-10030, 2019 05 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31043566
12.
Feasibility and utility of transbronchial cryobiopsy in precision medicine for lung cancer: Prospective single-arm study.
Cancer Sci;
111(7): 2488-2498, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32426898
13.
Ramucirumab or placebo plus erlotinib in EGFR-mutated, metastatic non-small-cell lung cancer: East Asian subset of RELAY.
Cancer Sci;
111(12): 4510-4525, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32954593
14.
A randomized, phase 2 study of deoxyuridine triphosphatase inhibitor, TAS-114, in combination with S-1 versus S-1 alone in patients with advanced non-small-cell lung cancer.
Invest New Drugs;
38(5): 1588-1597, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32246224
15.
Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol;
20(12): 1655-1669, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31591063
16.
Phase II study of nab-paclitaxel + carboplatin for patients with non-small-cell lung cancer and interstitial lung disease.
Cancer Sci;
110(12): 3738-3745, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31608537
17.
Phase I dose-escalation study of capmatinib (INC280) in Japanese patients with advanced solid tumors.
Cancer Sci;
110(4): 1340-1351, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30724423
18.
First-in-human phase 1 study of novel dUTPase inhibitor TAS-114 in combination with S-1 in Japanese patients with advanced solid tumors.
Invest New Drugs;
37(3): 507-518, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30511200
19.
Pattern of care in adjuvant therapy for resected Stage I non-small cell lung cancer: real-world data from Japan.
Jpn J Clin Oncol;
49(1): 63-68, 2019 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30452719
20.
Osimertinib in patients with epidermal growth factor receptor T790M advanced non-small cell lung cancer selected using cytology samples.
Cancer Sci;
109(4): 1177-1184, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29363250